CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination

Autoimmunity

Volumn 42, Issue 6, 2009, Pages 484-491

  Stiles, Linda N ^a   Liu, Michael T ^a   Kane, Joy C ^a   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Demyelination; T cells; Virus

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL10 ANTIBODY; CYTOKINE ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; DEMYELINATING DISEASE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MOUSE STRAIN; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINE CXCL10; CHEMOTAXIS, LEUKOCYTE; CORONAVIRUS INFECTIONS; DEMYELINATING DISEASES; MALE; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; RECEPTORS, CXCR3; SPINAL CORD; T-LYMPHOCYTES;

EID: 70249092892     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902810708     Document Type: Article

References (33)

1. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392(6676):565-568.
2. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338(7):436-445.
3. Thelen M. Dancing to the tune of chemokines. Nat Immunol 2001;2(2):129-134.
4. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002;168(7): 3195-3204.
5. Glass WG, Lane TE. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system. Virology 2003;312(2):407-414.
6. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival inWest Nile virus infection. J Exp Med 2005;202(8):1087-1098.
7. Liu MT, Armstrong D, Hamilton TA, Lane TE. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001; 166(3):1790-1795.
8. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. The T cell chemoattractant IFNinducible protein 10 is essential in host defense against viralinduced neurologic disease. J Immunol 2000;165(5): 2327-2330.
9. Liu MT, Keirstead HS, Lane TE. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 2001;167(7): 4091-4097.
10. Trifilo MJ, Bergmann CC, Kuziel WA, Lane TE. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J Virol 2003;77(7):4004-4014.
11. Stiles LN, Hosking MP, Edwards RA, Strieter RM, Lane TE. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol 2006;36(3):613-622.
12. Holmes K, LaiM. Fields virology. In: B.N. Fields,D.M. Knipe, P.M. Howely., editors. Fields virology. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996. p 1075-1094.
13. McIntosh K. Fields virology. In: B.N. Fields, D.M. Knipe, P.M. Howely., editors. Fields virology. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996. p 401-430.
14. Marten NW, Stohlman SA, Bergmann CC. MHV infection of the CNS: Mechanisms of immune-mediated control. Viral Immunol 2001;14(1):1-18.
15. Bergmann CC, Yao Q, Lin M, Stohlman SA. The JHM strain of mouse hepatitis virus induces a spike protein-specific Dbrestricted cytotoxic T cell response. J Gen Virol 1996;77(Pt 2): 315-325.
16. Castro RF, Perlman S. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 1995;69(12): 8127-8131.
17. Xue S, Jaszewski A, Perlman S. Identification of a CD4+ T cell epitope within theMprotein of a neurotropic coronavirus. Virology 1995;208(1):173-179.
18. Houtman JJ, Fleming JO. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 1996;2(6): 361-376.
19. Lin MT, Stohlman SA, Hinton DR. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 1997;71(1):383-391.
20. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999;162(3):1641-1647.
21. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. A central role for CD4(+) T cells and RANTES in virusinduced central nervous system inflammation and demyelination. J Virol 2000;74(3):1415-1424.
22. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000;165(4):2278-2286.
23. Tannenbaum CS, Tubbs R, ArmstrongD, Finke JH, Bukowski RM, Hamilton TA. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998;161(2):927-932.
24. Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE. T cell anti-viral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol 2006;177(12):8372-8380.
25. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001;167(8): 4585-4592.
26. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184(3):963-969.
27. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization. Eur J Immunol 1998;28(11):3696-3705.
28. Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 2004;172(7): 4018-4025.
29. Glass WG, Liu MT, Kuziel WA, Lane TE. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001;288(1):8-17.
30. Held KS, Chen BP, Kuziel WA, Rollins BJ, Lane TE. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology 2004;329(2):251-260.
31. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. Dynamic regulation of alpha- and betachemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998;160(2):970-978.
32. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005;79(17):11457-11466.
33. Marten NW, Stohlman SA, Bergmann CC. Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J Virol 2000;74(17):7903-7910.